These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 26238495

  • 21. Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats.
    Biernacki M, Łuczaj W, Gęgotek A, Toczek M, Bielawska K, Skrzydlewska E.
    Toxicol Appl Pharmacol; 2016 Jun 15; 301():31-41. PubMed ID: 27086176
    [Abstract] [Full Text] [Related]

  • 22. Different Routes to Inhibit Fatty Acid Amide Hydrolase: Do All Roads Lead to the Same Place?
    Giacovazzo G, Bisogno T, Piscitelli F, Verde R, Oddi S, Maccarrone M, Coccurello R.
    Int J Mol Sci; 2019 Sep 11; 20(18):. PubMed ID: 31514437
    [Abstract] [Full Text] [Related]

  • 23. URB597 improves cognitive impairment induced by chronic cerebral hypoperfusion by inhibiting mTOR-dependent autophagy.
    Wang D, Lin Q, Su S, Liu K, Wu Y, Hai J.
    Neuroscience; 2017 Mar 06; 344():293-304. PubMed ID: 28042028
    [Abstract] [Full Text] [Related]

  • 24. Beneficial Changes in Rat Vascular Endocannabinoid System in Primary Hypertension and under Treatment with Chronic Inhibition of Fatty Acid Amide Hydrolase by URB597.
    Baranowska-Kuczko M, Kozłowska H, Kloza M, Harasim-Symbor E, Biernacki M, Kasacka I, Malinowska B.
    Int J Mol Sci; 2021 May 02; 22(9):. PubMed ID: 34063297
    [Abstract] [Full Text] [Related]

  • 25. Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats.
    Scherma M, Panlilio LV, Fadda P, Fattore L, Gamaleddin I, Le Foll B, Justinová Z, Mikics E, Haller J, Medalie J, Stroik J, Barnes C, Yasar S, Tanda G, Piomelli D, Fratta W, Goldberg SR.
    J Pharmacol Exp Ther; 2008 Nov 02; 327(2):482-90. PubMed ID: 18725543
    [Abstract] [Full Text] [Related]

  • 26. Fatty acid amide hydrolase inhibitor URB597 prevented tolerance and cognitive deficits induced by chronic morphine administration in rats.
    Hasanein P, Ghafari-Vahed M.
    Behav Pharmacol; 2016 Feb 02; 27(1):37-43. PubMed ID: 26274041
    [Abstract] [Full Text] [Related]

  • 27. Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597.
    Matricon J, Seillier A, Giuffrida A.
    Neurosci Res; 2016 Sep 02; 110():49-58. PubMed ID: 27091613
    [Abstract] [Full Text] [Related]

  • 28. Chronic inhibition of fatty acid amide hydrolase by URB597 produces differential effects on cardiac performance in normotensive and hypertensive rats.
    Pędzińska-Betiuk A, Weresa J, Toczek M, Baranowska-Kuczko M, Kasacka I, Harasim-Symbor E, Malinowska B.
    Br J Pharmacol; 2017 Jul 02; 174(13):2114-2129. PubMed ID: 28437860
    [Abstract] [Full Text] [Related]

  • 29. Interactions between environmental aversiveness and the anxiolytic effects of enhanced cannabinoid signaling by FAAH inhibition in rats.
    Haller J, Barna I, Barsvari B, Gyimesi Pelczer K, Yasar S, Panlilio LV, Goldberg S.
    Psychopharmacology (Berl); 2009 Jul 02; 204(4):607-16. PubMed ID: 19259645
    [Abstract] [Full Text] [Related]

  • 30. Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation.
    Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G, Piomelli D.
    J Pharmacol Exp Ther; 2005 Apr 02; 313(1):352-8. PubMed ID: 15579492
    [Abstract] [Full Text] [Related]

  • 31. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats.
    Forget B, Guranda M, Gamaleddin I, Goldberg SR, Le Foll B.
    Psychopharmacology (Berl); 2016 May 02; 233(10):1823-8. PubMed ID: 26864774
    [Abstract] [Full Text] [Related]

  • 32. Fatty acid amide hydrolase (FAAH) inhibition reduces L-3,4-dihydroxyphenylalanine-induced hyperactivity in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned non-human primate model of Parkinson's disease.
    Johnston TH, Huot P, Fox SH, Wakefield JD, Sykes KA, Bartolini WP, Milne GT, Pearson JP, Brotchie JM.
    J Pharmacol Exp Ther; 2011 Feb 02; 336(2):423-30. PubMed ID: 20966038
    [Abstract] [Full Text] [Related]

  • 33. Endocannabinoid modulation of amphetamine sensitization is disrupted in a rodent model of lesion-induced dopamine dysregulation.
    Eisenstein SA, Holmes PV, Hohmann AG.
    Synapse; 2009 Nov 02; 63(11):941-50. PubMed ID: 19593824
    [Abstract] [Full Text] [Related]

  • 34. The effects of anandamide signaling enhanced by the FAAH inhibitor URB597 on coping styles in rats.
    Haller J, Goldberg SR, Pelczer KG, Aliczki M, Panlilio LV.
    Psychopharmacology (Berl); 2013 Dec 02; 230(3):353-62. PubMed ID: 23743650
    [Abstract] [Full Text] [Related]

  • 35. FAAH inhibition as a preventive treatment for migraine: A pre-clinical study.
    Greco R, Demartini C, Zanaboni AM, Tumelero E, Reggiani A, Misto A, Piomelli D, Tassorelli C.
    Neurobiol Dis; 2020 Feb 02; 134():104624. PubMed ID: 31629892
    [Abstract] [Full Text] [Related]

  • 36. Neuroprotective Effects of VEGF-A Nanofiber Membrane and FAAH Inhibitor URB597 Against Oxygen-Glucose Deprivation-Induced Ischemic Neuronal Injury.
    Wang DP, Jin KY, Zhao P, Lin Q, Kang K, Hai J.
    Int J Nanomedicine; 2021 Feb 02; 16():3661-3678. PubMed ID: 34093011
    [Abstract] [Full Text] [Related]

  • 37. Sex differences in hippocampal response to endocannabinoids after exposure to severe stress.
    Zer-Aviv TM, Akirav I.
    Hippocampus; 2016 Jul 02; 26(7):947-57. PubMed ID: 26928784
    [Abstract] [Full Text] [Related]

  • 38. The effects of enhancing endocannabinoid signaling and blocking corticotrophin releasing factor receptor in the amygdala and hippocampus on the consolidation of a stressful event.
    Aisenberg N, Serova L, Sabban EL, Akirav I.
    Eur Neuropsychopharmacol; 2017 Sep 02; 27(9):913-927. PubMed ID: 28663121
    [Abstract] [Full Text] [Related]

  • 39. The fatty acid amide hydrolase inhibitor URB597 (cyclohexylcarbamic acid 3'-carbamoylbiphenyl-3-yl ester) reduces neuropathic pain after oral administration in mice.
    Russo R, Loverme J, La Rana G, Compton TR, Parrott J, Duranti A, Tontini A, Mor M, Tarzia G, Calignano A, Piomelli D.
    J Pharmacol Exp Ther; 2007 Jul 02; 322(1):236-42. PubMed ID: 17412883
    [Abstract] [Full Text] [Related]

  • 40. Blockade of alcohol escalation and "relapse" drinking by pharmacological FAAH inhibition in male and female C57BL/6J mice.
    Zhou Y, Schwartz BI, Giza J, Gross SS, Lee FS, Kreek MJ.
    Psychopharmacology (Berl); 2017 Oct 02; 234(19):2955-2970. PubMed ID: 28730283
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.